These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35547738)

  • 1. Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
    Tajuelo A; Carretero O; García-Ríos E; López-Siles M; Cano O; Vázquez M; Más V; Rodríguez-Goncer I; Lalueza A; López-Medrano F; Juan RS; Fernández-Ruiz M; Aguado JM; McConnell MJ; Pérez-Romero P
    Front Immunol; 2022; 13():878812. PubMed ID: 35547738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike protein after natural infection or COVID-19 vaccination.
    Sariol CA; Pantoja P; Serrano-Collazo C; Rosa-Arocho T; Armina A; Cruz L; Stone ET; Arana T; Climent C; Latoni G; Atehortua D; Pabon-Carrero C; Pinto AK; Brien JD; Espino AM
    medRxiv; 2021 Aug; ():. PubMed ID: 34100029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-specific humoral immune response in Bulgarian COVID-19 patients with varying disease severity.
    Shikova E; Marteva-Proevska Y; Mondeshki T; Bilyukov R; Marinova D; Naumova E
    J Infect Dev Ctries; 2023 Dec; 17(12):1674-1681. PubMed ID: 38252713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of IL-6 serum level in COVID-19 patients with positive COVID-19 IgG/IgM antibody titers to check inflammation and disease progression.
    Mollazadeh S; Mahmoudi M; Mohammadi M; Kamal Kheder R; Nasiri Mahallati H; Sarbaz Haghighi S; Masoumi E; Javanmardi Z; Esmaeili SA
    Cytokine; 2024 May; 177():156564. PubMed ID: 38432065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Kinetics in Unvaccinated Hospitalized Children With COVID-19.
    Dimopoulou D; Charakida M; Marmarinos A; Karaviti D; Avgeris M; Gourgiotis D; Tsolia MN
    Pediatr Infect Dis J; 2024 Jun; 43(6):536-542. PubMed ID: 38372544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.
    Borgogna C; Bruna R; Griffante G; Martuscelli L; De Andrea M; Ferrante D; Patriarca A; Mahmoud AM; Gaidano V; Marchetti M; Rapezzi D; Lai M; Pistello M; Ladetto M; Massaia M; Gaidano G; Gariglio M
    Blood Cancer J; 2022 Jan; 12(1):8. PubMed ID: 35042847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses.
    Spatola M; Nziza N; Jung W; Deng Y; Yuan D; Dinoto A; Bozzetti S; Chiodega V; Ferrari S; Lauffenburger DA; Mariotto S; Alter G
    Brain; 2023 Oct; 146(10):4292-4305. PubMed ID: 37161609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.
    Suthar MS; Zimmerman MG; Kauffman RC; Mantus G; Linderman SL; Hudson WH; Vanderheiden A; Nyhoff L; Davis CW; Adekunle O; Affer M; Sherman M; Reynolds S; Verkerke HP; Alter DN; Guarner J; Bryksin J; Horwath MC; Arthur CM; Saakadze N; Smith GH; Edupuganti S; Scherer EM; Hellmeister K; Cheng A; Morales JA; Neish AS; Stowell SR; Frank F; Ortlund E; Anderson EJ; Menachery VD; Rouphael N; Mehta AK; Stephens DS; Ahmed R; Roback JD; Wrammert J
    Cell Rep Med; 2020 Jun; 1(3):100040. PubMed ID: 32835303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity.
    Elyanow R; Snyder TM; Dalai SC; Gittelman RM; Boonyaratanakornkit J; Wald A; Selke S; Wener MH; Morishima C; Greninger AL; Gale M; Hsiang TY; Jing L; Holbrook MR; Kaplan IM; Zahid HJ; May DH; Carlson JM; Baldo L; Manley T; Robins HS; Koelle DM
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35439166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection.
    Muir L; Jaffer A; Rees-Spear C; Gopalan V; Chang FY; Fernando R; Vaitkute G; Roustan C; Rosa A; Earl C; Rajakaruna GK; Cherepanov P; Salama A; McCoy LE; Motallebzadeh R
    Kidney Int Rep; 2021 Jul; 6(7):1799-1809. PubMed ID: 33942026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management.
    von Possel R; Menge B; Deschermeier C; Fritzsche C; Hemmer C; Geerdes-Fenge H; Loebermann M; Schulz A; Lattwein E; Steinhagen K; Tönnies R; Ahrendt R; Emmerich P
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study.
    Foley MK; Searle SD; Toloue A; Booth R; Falkenham A; Falzarano D; Rubino S; Francis ME; McNeil M; Richardson C; LeBlanc J; Oldford S; Gerdts V; Andrew MK; McNeil SA; Clarke B; Rockwood K; Kelvin DJ; Kelvin AA
    EClinicalMedicine; 2021 Jul; 37():100975. PubMed ID: 34222846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.
    Jacobs JL; Bain W; Naqvi A; Staines B; Castanha PMS; Yang H; Boltz VF; Barratt-Boyes S; Marques ETA; Mitchell SL; Methé B; Olonisakin TF; Haidar G; Burke TW; Petzold E; Denny T; Woods CW; McVerry BJ; Lee JS; Watkins SC; St Croix CM; Morris A; Kearney MF; Ladinsky MS; Bjorkman PJ; Kitsios GD; Mellors JW
    Clin Infect Dis; 2022 May; 74(9):1525-1533. PubMed ID: 34374761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.
    Keijzer S; Oskam N; Ooijevaar-de Heer P; Steenhuis M; Keijser JBD; Wieske L; van Dam KPJ; Stalman EW; Kummer LYL; Boekel L; Kuijpers TW; Ten Brinke A; van Ham SM; Eftimov F; Tas SW; Wolbink GJ; Rispens T
    Front Immunol; 2024; 15():1314507. PubMed ID: 38487524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin genes and severity of COVID-19.
    Vázquez-Coto D; Kimball C; Albaiceta GM; Amado-Rodríguez L; García-Clemente M; Gómez J; Coto E; Pandey JP
    Immunogenetics; 2024 Jun; 76(3):213-217. PubMed ID: 38602517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase.
    Peraire J; García-Pardo G; Chafino S; Sánchez A; Botero-Gallego M; Olona M; Espineira S; Reverté L; Skouridou V; Peiró ÓM; Gómez-Bertomeu F; Vidal F; O' Sullivan CK; Rull A
    Eur J Med Res; 2024 Apr; 29(1):223. PubMed ID: 38581072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti_spike and anti_nucleocapsid IgG responses to SARS-CoV-2 in children of Jordan.
    Qaqish A; Abbas MM; Alkhateeb M; Al-Tamimi M; Mustafa M; Al-Shudifat AE; Tarawneh S; Dawoud R; Mryyian A; Al-Ajaleen M
    Heliyon; 2024 May; 10(9):e30631. PubMed ID: 38765100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV.
    Schnittman SR; Jung W; Fitch KV; Zanni MV; McCallum S; Lee JS; Shin S; Davis BJ; Fulda ES; Diggs MR; Giguel F; Chinchay R; Sheth AN; Fichtenbaum CJ; Malvestutto C; Aberg JA; Currier J; Lauffenburger DA; Douglas PS; Ribaudo HJ; Alter G; Grinspoon SK
    JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36805331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological Signatures in Blood and Urine in 80 Individuals Hospitalized during the Initial Phase of COVID-19 Pandemic with Quantified Nicotine Exposure.
    Laudanski K; Mahmoud MA; Ahmed AS; Susztak K; Mathew A; Chen J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition.
    Haslund-Gourley BS; Woloszczuk K; Hou J; Connors J; Cusimano G; Bell M; Taramangalam B; Fourati S; Mege N; Bernui M; Altman MC; Krammer F; van Bakel H; ; Maecker HT; Rouphael N; Diray-Arce J; Wigdahl B; Kutzler MA; Cairns CB; Haddad EK; Comunale MA
    Nat Commun; 2024 Jan; 15(1):404. PubMed ID: 38195739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.